Biotech Acquisition Company (NASDAQ:BIOT) announced in an 8-K that it has agreed to sell most of its sponsor economics and undergo a management change.
An investor registered as IREEM LLC is purchasing 5,455,000 of Biotech’s promote shares (94.8%) and all 6,000,000 of its private placement warrants for $470,000 in total.
The outgoing team featured experience at a variety of European biotech venture capital firms and is to be replaced by primarily US-focused officers. The SPAC has not yet announced a new name or focus, but its incoming team suggests it could go in a number of different directions.
Laxmi Prasad Palaypu is to serve as CEO and chairman and also chairs New York-based boutique investment firm Interups (OTC:ITUP). Incoming CFO Jon Paul specializes in cannabis industry growth initiatives out of Las Vegas, Nevada. The SPAC’s new Board, meanwhile, features members ranging in experience from pharmaceutical research to steel production and municipal services.
Interups also specializes in deploying funds from Indian wealth management and retirement accounts into REIT and InvIT structures, but this may not be a hint at where the SPAC will look.
The new team’s first task will be getting as much of the SPAC’s estimated $232 million in trust through an extension vote. Biotech’s original transaction deadline is coming up on January 27, 2023 and it has already filed a pre-proxy for a vote without setting a date.
This proxy outlined a 10-month extension to October 27, 2023, and did not include a finalized amount for any proposed contribution to trust.
Vehicle data-tracker Wejo (NASDAQ:WEJO) announced in an 8-K this afternoon that it has filed its intention to appoint an administrator to oversee its insolvency and it is evaluating whether it will do so in the United States as well. The company, which completed a de-SPAC transaction with Virtuoso in November 2021, has another SPAC deal...
Aimei Health Technology Co. (NASDAQ:AFJK) filed its S-1 Friday afternoon for a $50 million IPO, marking the fourth SPAC to file for an IPO in May and the twelfth year-to-date. Given its name, it comes as no surprise that Aimei Health Technology intends to pursue prospective targets that are focused on healthcare innovation. More specifically, the...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: GreenLight Biosciences returns to private market, Jet.AI partners with Vegas Golden Knights and Cirrus Aviation, and True Velocity announces partnership with FN America GreenLight returns to private market in $46M deal after taste of...
GreenLight Biosciences (NASDAQ:GRNA), which combined with Environmental Impact in February 2022, announced this morning that it is being acquired in a go-private transaction by Fall Line Capital for $45.5 million. While this is a steep valuation decline from its $1.23 billion enterprise value at the announcement of its SPAC deal, this price does represent a...
FOXO Technologies Inc. (NYSE:FOXO), which completed its business combination with Delwinds Insurance in September 2022, announced this morning that it has consummated its exchange offer for all outstanding warrants as well as its PIK note offer to amend. As part of the offer, all holders of FOXO’s warrants received 4.83 shares of Class A common...